相关实验视频
Updated: Sep 14, 2025

14:54
A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
Published on: January 27, 2019
11.2K
儿科败血症中血蛋白质组的动态变化和临床影响
Shiyuan Fan1,2, Xinglv Liu1, Zichi Zhao1
1Hunan Provincial People's Hospital and The First Affiliated Hospital of Hunan Normal University, 61 Jie-Fang West Road, Fu-Rong District, Changsha, 410005, Hunan, People's Republic of China.
European journal of medical research
|July 23, 2025
概括
质谱学在败血症小鼠中发现了161种改变的血蛋白,揭示了关键的途径. 在儿童中,五个生物标志物 (AT III,CFD,Col1α1,EGFR,Thbs1) 降低,与败血症中的免疫和凝血功能相关.
科学领域:
- 蛋白质组学是指蛋白质组学.
- 生物标志物发现发现
- 儿科败血症研究研究
背景情况:
- 目前的败血症生物标志物在识别高风险患者和了解疾病机制方面存在局限性.
- 基于质谱的蛋白质组学为儿童败血症的个性化生物标志物和治疗策略识别提供了潜力.
研究的目的:
- 通过基于质谱的蛋白质组学来识别儿科败血症的新型血蛋白生物标志物.
- 调查候选生物标志物与儿科败血症患者的临床参数和免疫/凝血功能的相关性.
主要方法:
- 液体染色学-质谱学 (LC/MS) 蛋白质组学是在多个时间点的年轻小鼠的血样本上进行的.
- 蛋白质组数据与66名儿科败血症患者的临床数据相关联,包括ELISA验证和免疫学测试.
- 分析了候选生物标志物与凝血参数 (PT,APTT,INR,D-Dimer,Fbg) 和免疫细胞 (CD8+,B细胞,CD4+/CD8+) 的相关性.
主要成果:
- 在败血症小鼠中鉴定出161种差异上调的血蛋白,在补充和凝血级联,焦点粘附和胞体通路中进行丰富.
- 五个候选生物标志物 (AT III,CFD,Col1α1,EGFR,Thbs1) 在儿科败血症患者的水平下降.
- 候选生物标志物与各种凝血因子和免疫细胞种群具有显著的相关性,表明它们参与了败血症病理生理学.
结论:
- 在小鼠的蛋白质组分析中,确定了与败血症有关的关键途径,包括补充和凝血级联.
- 在儿科败血症患者中,AT III,CFD,Col1α1,EGFR和Thbs1的水平降低表明它们有可能作为诊断或预后生物标志物.
- 已识别的生物标志物与血症的凝血和免疫失调有关,突出了潜在的治疗点.
相关概念视频
Acute Kidney Injury II: Pathophysiology
81
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
81
Acute Kidney Injury III: Clinical Manifestations
94
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
94
Nephrotic Syndrome I : Introduction
29
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
29
Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
Factors Affecting Protein-Drug Binding: Patient-Related Factors
114
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
114
Acute Kidney Injury I: Introduction
76
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
76

